COVID-19 transmission in dental and oral/maxillofacial surgical practice during pandemic: questionnaire survey in 51 university hospitals in Japan. 2022

H Tanaka, and H Kurita, and Y Shibuya, and D Chikazu, and M Iino, and K Hoshi, and W Kobayashi, and S Yokoo, and K Kawano, and K Mitsudo, and A Miyazaki, and Y Ota, and H Kishimoto, and Y Mori, and T Yamamoto
Department of Dentistry and Oral Surgery, Shinshu University School of Medicine, Matsumoto, Japan.

BACKGROUND The coronavirus disease 2019 (COVID-19) pandemic has become a major public health problem. Dental procedures that generate aerosols are considered to impose a high risk of infection; therefore, dental professionals, such as dentists and dental hygienists, may be at high risk of viral transmission. However, few studies have reported COVID-19 clusters in dental care settings. OBJECTIVE To investigate whether dental and oral/maxillofacial procedures are associated with the occurrence of COVID-19 clusters and measures taken to prevent nosocomial infection in dental clinics. METHODS An online questionnaire survey on clinical activities (administrative control), infection control measures (environmental/engineering control, personal protective equipment, etc.), and confirmed or probable COVID-19 cases among patients and clinical staff was administered to the faculties of the dental and oral/maxillofacial surgical departments of university hospitals. RESULTS Fifty-one faculty members completed the questionnaire. All members were engaged in the treatment of dental and oral surgical outpatients and actively implemented standard precautions. Fourteen faculty members treated patients with COVID-19, but no infections transmitted from the patients to the medical staff were observed. In seven facilities, patients were found to have the infection after treatment (medical staff came in close contact), but there was no transmission from patients to medical staff. Four facilities had medical staff with infections, but none of them exhibited disease transmission from staff to patients. CONCLUSIONS COVID-19 clusters are unlikely to occur in dental and oral surgical care settings if appropriate protective measures are implemented.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D011795 Surveys and Questionnaires Collections of data obtained from voluntary subjects. The information usually takes the form of answers to questions, or suggestions. Community Survey,Nonrespondent,Questionnaire,Questionnaires,Respondent,Survey,Survey Method,Survey Methods,Surveys,Baseline Survey,Community Surveys,Methodology, Survey,Nonrespondents,Questionnaire Design,Randomized Response Technique,Repeated Rounds of Survey,Respondents,Survey Methodology,Baseline Surveys,Design, Questionnaire,Designs, Questionnaire,Methods, Survey,Questionnaire Designs,Questionnaires and Surveys,Randomized Response Techniques,Response Technique, Randomized,Response Techniques, Randomized,Survey, Baseline,Survey, Community,Surveys, Baseline,Surveys, Community,Techniques, Randomized Response
D006785 Hospitals, University Hospitals maintained by a university for the teaching of medical students, postgraduate training programs, and clinical research. University Hospitals
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067393 Personal Protective Equipment Specialized clothing or equipment worn for protection against health hazards. Personal Protective Equipment may include MASKS; RESPIRATORY PROTECTIVE DEVICES; HEAD PROTECTIVE DEVICES; EYE PROTECTIVE DEVICES; EAR PROTECTIVE DEVICES; PROTECTIVE CLOTHING; and protective footwear. PPE Personal Protective Equipment,Equipment, Personal Protective,Personal Protective Equipments,Protective Equipment, Personal
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic

Related Publications

H Tanaka, and H Kurita, and Y Shibuya, and D Chikazu, and M Iino, and K Hoshi, and W Kobayashi, and S Yokoo, and K Kawano, and K Mitsudo, and A Miyazaki, and Y Ota, and H Kishimoto, and Y Mori, and T Yamamoto
January 2021, Journal of family medicine and primary care,
H Tanaka, and H Kurita, and Y Shibuya, and D Chikazu, and M Iino, and K Hoshi, and W Kobayashi, and S Yokoo, and K Kawano, and K Mitsudo, and A Miyazaki, and Y Ota, and H Kishimoto, and Y Mori, and T Yamamoto
March 2004, The journal of ECT,
H Tanaka, and H Kurita, and Y Shibuya, and D Chikazu, and M Iino, and K Hoshi, and W Kobayashi, and S Yokoo, and K Kawano, and K Mitsudo, and A Miyazaki, and Y Ota, and H Kishimoto, and Y Mori, and T Yamamoto
January 2021, The British journal of oral & maxillofacial surgery,
H Tanaka, and H Kurita, and Y Shibuya, and D Chikazu, and M Iino, and K Hoshi, and W Kobayashi, and S Yokoo, and K Kawano, and K Mitsudo, and A Miyazaki, and Y Ota, and H Kishimoto, and Y Mori, and T Yamamoto
October 2020, BMC health services research,
H Tanaka, and H Kurita, and Y Shibuya, and D Chikazu, and M Iino, and K Hoshi, and W Kobayashi, and S Yokoo, and K Kawano, and K Mitsudo, and A Miyazaki, and Y Ota, and H Kishimoto, and Y Mori, and T Yamamoto
November 2023, The Journal of asthma : official journal of the Association for the Care of Asthma,
H Tanaka, and H Kurita, and Y Shibuya, and D Chikazu, and M Iino, and K Hoshi, and W Kobayashi, and S Yokoo, and K Kawano, and K Mitsudo, and A Miyazaki, and Y Ota, and H Kishimoto, and Y Mori, and T Yamamoto
August 2021, Current opinion in infectious diseases,
H Tanaka, and H Kurita, and Y Shibuya, and D Chikazu, and M Iino, and K Hoshi, and W Kobayashi, and S Yokoo, and K Kawano, and K Mitsudo, and A Miyazaki, and Y Ota, and H Kishimoto, and Y Mori, and T Yamamoto
January 2022, Frontiers in psychology,
H Tanaka, and H Kurita, and Y Shibuya, and D Chikazu, and M Iino, and K Hoshi, and W Kobayashi, and S Yokoo, and K Kawano, and K Mitsudo, and A Miyazaki, and Y Ota, and H Kishimoto, and Y Mori, and T Yamamoto
May 2023, BMC oral health,
H Tanaka, and H Kurita, and Y Shibuya, and D Chikazu, and M Iino, and K Hoshi, and W Kobayashi, and S Yokoo, and K Kawano, and K Mitsudo, and A Miyazaki, and Y Ota, and H Kishimoto, and Y Mori, and T Yamamoto
January 2020, Tropical medicine and health,
H Tanaka, and H Kurita, and Y Shibuya, and D Chikazu, and M Iino, and K Hoshi, and W Kobayashi, and S Yokoo, and K Kawano, and K Mitsudo, and A Miyazaki, and Y Ota, and H Kishimoto, and Y Mori, and T Yamamoto
January 2022, Frontiers in oral health,
Copied contents to your clipboard!